Evidence map›Paper›PMID 19116350›Full record

ArticleJournal of clinical microbiology2009

Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR.

Mingjun Jiang, Janet G Baseman, Laura A Koutsky, Qinghua Feng, Constance Mao, Nancy B Kiviat, Long Fu Xi

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mingjun JiangDepartment of Pathology, School of Medicine, University of Washington, Seattle, Washington, USA.
Janet G Baseman
Laura A Koutsky
Qinghua Feng
Constance Mao
Nancy B Kiviat
Long Fu Xi

Funding

ETIOLOGY AND NATURAL HISTORY OF CERVICAL NEOPLASIAR01CA034493 · NCI · UNIVERSITY OF WASHINGTON · PI KOUTSKY, LAURA A · 1985 to 2007
$4.3M
EPIDEMIOLOGY OF HPV16/18 VARIANTS IN CERVICAL NEOPLASIAR01CA084396 · NCI · UNIVERSITY OF WASHINGTON · PI XI, LONG FU · 2000 to 2003
$1.0M
NCI NIH HHS CA34493NCI NIH HHS CA84396NCI NIH HHS R01 CA034493NCI NIH HHS R01 CA084396
6 · The paper itself

Abstract

Given that the integration of human papillomavirus type 16 (HPV16) into the host genome occurs preferentially with the disruption of the E2 gene, a ratio of E2 to E7 gene copies is often used as a marker for integration. It is largely undetermined, however, whether ratio estimates are affected by HPV intratypic variations. We assembled four plasmid constructs, each containing a DNA fragment from an HPV16 European, Asian-American, African-1, or African-2 variant. These constructs and nine cervical swab samples were assayed by real-time PCR with two primer-probe sets for each gene: a specific set, fully complementary to the HPV16 prototype, and a degenerate set, incorporating degenerate bases at positions where nucleotides differed among the variants. The ratio of E2 to E7 gene copies for the European variant construct was close to 1, no matter which sets of primers and probes were used. While the ratios for the African-1 and Asian-American variant constructs remained close to 1 with the degenerate sets of primers and probes, the ratios were 0.36 and 2.57, respectively, with the specific sets of primers and probes. In addition, a nucleotide alteration at the position immediately following the 3' end of the E2 forward primer binding site was found to be responsible for an underestimation of E2 gene copies for the African-2 variant construct. Similar patterns were found in nine cervical samples. In conclusion, mismatches between the primers and probes and their targets due to HPV16 intratypic variations would introduce errors in testing for integration; this situation can be sufficiently ameliorated by incorporating degenerate bases into the primers and probes.

Indexed as

Virus IntegrationBase Pair MismatchCervix UteriDNA-Binding ProteinsDNA PrimersFemaleHuman papillomavirus 16HumansOncogene Proteins, ViralPapillomavirus E7 ProteinsPapillomavirus InfectionsPlasmidsPolymerase Chain ReactionSensitivity and SpecificityDNA-Binding ProteinsDNA PrimersE2 protein, Human papillomavirus type 16oncogene protein E7, Human papillomavirus type 16Oncogene Proteins, ViralPapillomavirus E7 Proteins

Identifiers

PMID19116350
PMCPMC2650947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.